Factors
Entities
Emergency Use AuthorizationHoly GrailMantraBangladeshi takaPalestraInnaNimWarsawIbuprofenEuropean Medicines AgencyNational Institutes of HealthZika virusParacetamolFrankfurter Allgemeine ZeitungSamoTejTempoFood and Drug AdministrationDNAHIVJanus kinaseEuropean UnionRokuPfizerVaccineUnited StatesSevere acute respiratory syndrome coronavirus 2Good clinical practiceRola coat of armsPlacebo-controlled studyClinicalTrials.govCompetition and Markets Authority
